UK markets closed

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
5.13+0.10 (+1.99%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-7,499
-7,019
-16,925
237
-5,774
-
Depreciation & amortisation
1,102
1,102
1,076
773
660
-
Stock-based compensation
1,713
1,937
2,174
1,597
1,674
-
Change in working capital
1,906
848
-544
216
-911
-
Accounts receivable
233
9
261
560
-751
-
Inventory
1,166
749
-312
181
-374
-
Accounts payable
234
-153
99
236
-35
-
Other working capital
-3,457
-3,717
-15,014
912
-4,970
-
Other non-cash items
-185
-28
-87
-151
-40
-
Net cash provided by operating activities
-2,566
-2,763
-13,698
2,501
-4,451
-
Cash flows from investing activities
Investments in property, plant and equipment
-891
-954
-1,316
-1,589
-519
-
Purchases of investments
-
0
-20,000
-30,000
0
-
Sales/maturities of investments
-
0
50,238
0
0
-
Other investing activities
-
-270
-
-
-
-
Net cash used for investing activities
-1,093
-1,156
28,922
-31,556
-519
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-24
-20
Common stock issued
-
0
0
32,743
4,400
-
Other financing activities
-
-
-
-
-
-17
Net cash used provided by (used for) financing activities
314
1,108
1,874
38,760
4,465
-
Net change in cash
-3,442
-3,190
16,490
9,848
-445
-
Cash at beginning of period
26,790
29,864
13,374
3,526
3,971
-
Cash at end of period
23,445
26,674
29,864
13,374
3,526
-
Free cash flow
Operating cash flow
-2,566
-2,763
-13,698
2,501
-4,451
-
Capital expenditure
-891
-954
-1,316
-1,589
-519
-
Free cash flow
-3,457
-3,717
-15,014
912
-4,970
-